Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 13, 2013 - Issue 6
Submit an article Journal homepage
520
Views
29
CrossRef citations to date
0
Altmetric
Reviews

Cost–effectiveness analysis of rheumatic heart disease prevention strategies

Rizwan A ManjiDepartment of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada;Department of Anesthesia, University of Manitoba, Winnipeg, Manitoba, Canada
,
Julia WittDepartment of Economics, University of Manitoba, Winnipeg, Manitoba, Canada
,
Paramjit S TappiaSt. Boniface Hospital, Asper Clinical Research Institute & Office of Clinical Research, Winnipeg, Manitoba, CanadaCorrespondence[email protected]
,
Young JungDepartment of Economics, University of Manitoba, Winnipeg, Manitoba, Canada
,
Alan H MenkisDepartment of Surgery, University of Manitoba, Winnipeg, Manitoba, Canada
&
Bram RamjiawanSt. Boniface Hospital, Asper Clinical Research Institute & Office of Clinical Research, Winnipeg, Manitoba, Canada
Pages 715-724 | Published online: 09 Jan 2014

References

  • Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 366(9480), 155–168 (2005).
  • Marijon E, Mirabel M, Celermajer DS, Jouven X. Rheumatic heart disease. Lancet 379(9819), 953–964 (2012).
  • Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special writing group of the committee on rheumatic fever, endocarditis, and Kawasaki Disease of the council on cardiovascular disease in the young of the American Heart Association. J. Am. Med. Assoc. 268(15), 2069–2073 (1992).
  • Karthikeyan G, Zühlke L, Engel Met al. Rationale and design of a Global Rheumatic Heart Disease Registry: the REMEDY study. Am. Heart J. 163(4), 535–540 (2012).
  • Sliwa K, Zilla P. Rheumatic heart disease: the tip of the iceberg. Circulation 125(25), 3060–3062 (2012).
  • Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5(11), 685–694 (2005).
  • Michaud C, Trejo-Gutierrez, Cruz C, Pearson TA. The world Bank Health Sector Priorities Review: Rheumatic Heart Disease. World Bank, Washington, DC, USA, 1–31 (1991).
  • Jaiyesimi F. Chronic rheumatic heart disease in childhood: its cost and economic implications. Trop. Cardiol. 8, 55–59 (1982).
  • Strasser T. Cost-effective control of rheumatic fever in the community. Health Policy 5(2), 159–164 (1985).
  • Tani LY, Veasy LG, Minich LL, Shaddy RE. Rheumatic fever in children younger than 5 years: is the presentation different. Pediatrics 112(5), 1065–1068 (2003).
  • Pelajo CF, Lopez-Benitez JM, Torres JM, de Oliveira SK. Adherence to secondary prophylaxis and disease recurrence in 536 Brazilian children with rheumatic fever. Pediatr. Rheumatol. Online J. 8, 22 (2010).
  • Reeves BM, Kado J, Brook M. High prevalence of rheumatic heart disease in Fiji detected by echocardiography screening. J. Paediatr. Child Health 47(7), 473–478 (2011).
  • Longo-Mbenza B, Bayekula M, Ngiyulu Ret al. Survey of rheumatic heart disease in school children of Kinshasa town. Int. J. Cardiol. 63(3), 287–294 (1998).
  • Oli K, Porteous J. Rheumatic heart disease among school children in Addis Ababa City: awareness and adequacy of its prophylaxis. Ethiop. Med. J. 37(3), 155–161 (1999).
  • Oli K, Asmera J. Rheumatic heart disease in Ethiopia: could it be more malignant. Ethiop. Med. J. 42(1), 1–8 (2005).
  • Marijon E, Ou P, Celermajer DSet al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N. Engl. J. Med. 357(5), 470–476 (2007).
  • Saxena A, Ramakrishnan S, Roy Aet al. Prevalence and outcome of sunclinical rheumatic heart disease in India: the RHEUMATIC (Rheumatic Heart Echo Utilisation and Monitoring Actuarial Trends in Indian Children) study. Heart 97(24), 2018–2022 (2011).
  • Beaton A, Okello E, Lwabi Pet al. Echocardiography in screening for rheumatic heart disease in Ugandan schoolchildren. Circulation 125(25), 3127–3132 (2012).
  • King A. Public health: value of echocardiographic screening for RHD in Ugandan children. Nat. Rev. Cardiol. 9(8), 433 (2012).
  • Marijon E, Celermajer DS, Tafflet Met al. Rheumatic heart disease screening by echocardiography: the inadequacy of World Health Organization criteria for optimizing the diagnosis of subclinical disease. Circulation 120(8), 663–668 (2009).
  • Mirabel M, Celermajer DS, Ferreira Bet al. Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach. Eur. Heart J. Cardiovasc. Imaging 13(12), 1024–1029 (2012).
  • Kane A, Mirabel M, Touré Ket al. Echocardiographic screening for rheumatic heart disease: age matters. Int. J. Cardiol. (2013) (Epub ahead of print).
  • Bhaya M, Beniwal R, Panwar S, Panwar RB. Two years of follow-up validates the echocardiographic criteria for the diagnosis and screening of rheumatic heart disease in asymptomatic populations. Echocardiography 28(9), 929–933 (2011).
  • Steer AC, Carapetis JR. Acute rheumatic fever and rheumatic heart disease in indigenous populations. Pediatr. Clin. North Am. 56(6), 1401–1419 (2009).
  • Eisenberg MJ. Rheumatic heart disease in the developing world: prevalence, prevention, and control. Eur. Heart J. 14(1), 122–128 (1993).
  • Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 96(4 Pt 1), 758–764 (1995).
  • Adanja B, Vlajinac H, Jarebinski M. Socioeconomic factors in the etiology of rheumatic fever. J. Hyg. Epidemiol. Microbiol. Immunol. 32(3), 329–335 (1988).
  • Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst. Rev. (3), CD002227 (2002).
  • Visvanathan K, Manjarez RC, Zabriskie JB. Rheumatic fever. Curr. Treat. Options Cardiovasc. Med. 1(3), 253–258 (1999).
  • Rayamajhi A, Sharma D, Shakya U. First-episode versus recurrent acute rheumatic fever: is it different. Pediatr. Int. 51(2), 269–275 (2009).
  • Ehrlich JE, Demopoulos BP, Daniel KRJr, Ricarte MC, Glied S. Cost-effectiveness of treatment options for prevention of rheumatic heart disease from Group A streptococcal pharyngitis in a pediatric population. Prev. Med. 35(3), 250–257 (2002).
  • Coulehan JL, Baacke G, Welty TK, Goldtooth NL. Cost-benefit of a streptococcal surveillance program among Navajo Indians. Public Health Rep. 97(1), 73–77 (1982).
  • Brant LJ, Bender TR, Bross DS. Evaluation of an Alaskan streptococcal control program: importance of the program's intensity and duration. Prev. Med. 15(6), 632–642 (1986).
  • Terreri MT, Ferraz MB, Goldenberg J, Len C, Hilário MO. Resource utilization and cost of rheumatic fever. J. Rheumatol. 28(6), 1394–1397 (2001).
  • Milne RJ, Lennon D, Stewart JM, Vander-Hoorn S, Schuffham PA. Mortality and hospitalization costs of rheumatic fever and rheumatic heart disease in New Zealand. J. Paediatr. Child Health 48(8), 692–697 (2012).
  • Hassell TA, Stuart KL. Rheumatic fever prophylaxis: a three-year study. Br. Med. J. 2(5909), 39–40 (1974).
  • Soudarssanane MB, Karthigeyan M, Mahalakshmy Tet al. Rheumatic fever and rheumatic heart disease: primary prevention is the cost effective option. Indian J. Pediatr. 74(6), 567–570 (2007).
  • Irlam J, Mayosi BM, Engel M, Gaziano TA. Primary prevention of acute rheumatic fever and rheumatic heart disease with penicillin in South African children with pharyngitis: a cost-effectiveness analysis. Circ. Cardiovasc. Qual. Outcomes 6(3). 343–351 (2013).
  • Sonnenberg FA, Beck R. Markov models in medical decision making: a practical guide. Med. Decis. Making 13(4), 322–338 (1993).
  • Sun X, Faunce T. Decision-analytical modelling in health-care economic evaluations. Eur. J. Health Econ. 9(4), 313–323 (2008).
  • Tani LY, Veasy LG, Minich LL, Shaddy RE. Rheumatic fever in children under 5 years. Pediatrics 114(3), 906 (2004).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.